Share

Liaoning Cheng Da Co., Ltd. Stocks

CN¥ 11.9Last Updated 30.04.2026

Issuer Rating

5/7
Performance

Modest

Risk

Low

Recommendation

Hold

Market Cap

CN¥ 2.56B

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 11.9
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Liaoning Cheng Da Co., Ltd. engages in trading, medicine and medical care, financial investment, and energy development businesses in China and internationally. The company trades in textile and apparel, chemical products, coal, aquatic products, timber, and steel; and offers medical insurance. It is also involved in the research, development, production, and marketing of human and veterinary vaccines; pharmaceutical retail and wholesale, and logistics distribution activities; the provision of medical enterprise management consulting; and sale of medical equipment. In addition, the company offers medical technology, computer hardware and software technology development, technology consulting and transfer, and technical services. Further, it engages in securities and fund activities; and the development of oil shale projects. Liaoning Cheng Da Co., Ltd. was founded in 1991 and is headquartered in Dalian, China.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'expensive' o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks